Prosta Peak Ingredients & Side Effects: Full Clinical Breakdown
Prosta Peak’s nine-ingredient formula covers the most evidence-supported pathways in prostate health — 5-alpha reductase inhibition, anti-inflammatory signaling, zinc repletion, and antioxidant protection — with its two marquee ingredients, Saw Palmetto (320 mg, 45% fatty acids) and Beta-Sitosterol (~200 mg), dosed at or within the ranges used in the most relevant clinical trials. The side effect profile across the full panel is favorable for most healthy men, with a few drug-interaction considerations worth knowing before you start. If you want the bottom line before the deep-dive: this is a well-constructed formula for the prostate supplement category, not a random list of trending botanicals, and the dosing rationale holds up to scrutiny better than most competing products in this space.
This analysis breaks down every ingredient against published clinical dose ranges, explains the mechanism of action in plain language, reviews the real PubMed evidence (positive and mixed alike), and gives you a complete side-effects and contraindications picture. I’m not going to tell you Prosta Peak cures BPH — no supplement does — but I’ll tell you exactly what each ingredient is reasonably expected to do at the dose present in this formula.
TL;DR — Key Findings
- Nine-ingredient formula targeting 5-alpha reductase inhibition, anti-inflammation, zinc status, and prostate antioxidant defense simultaneously
- Saw Palmetto (320 mg, 45% fatty acids) is at the canonical clinical dose — the same used in the majority of positive phase-III trials
- Beta-Sitosterol (~200 mg) has the strongest evidence in the panel — Cochrane review shows significant IPSS improvement and urinary flow increase vs. placebo
- Pygeum Africanum is backed by a Cochrane meta-analysis of 18 RCTs showing consistent urinary symptom improvement
- Lycopene and Broccoli Leaf Extract have epidemiological/preclinical evidence only — not established BPH treatments at these doses
- Green tea extract (EGCG): moderate dose with mild caffeine content; real drug interaction concern for men on blood thinners
- 60-day money-back guarantee from the vendor makes the trial window genuinely risk-free
See the Full Ingredient Panel on the Official Site{rel=“nofollow sponsored”}
The Complete Prosta Peak Ingredient Panel
Before the ingredient-by-ingredient deep-dive, here is the full panel cross-referenced against published clinical ranges. Evidence grades are my own assessment based on the peer-reviewed literature available as of 2026 for the specific indication (BPH / lower urinary tract symptoms / prostate health), not general biological activity.
| Ingredient | Claimed Dose | Clinical Trial Range | Evidence Grade | Notes |
|---|---|---|---|---|
| Saw Palmetto Extract (45% fatty acids) | ~320 mg | 160–320 mg/day | B+ | Most-studied prostate supplement; Cochrane evidence for urinary symptom improvement at this dose |
| Beta-Sitosterol | ~200 mg | 60–130 mg/day (divided) | A | Strongest evidence in panel; Cochrane RCT meta-analysis positive for IPSS + flow rate |
| Pygeum Africanum Bark Extract | ~100 mg | 25–200 mg/day | B+ | Cochrane meta-analysis of 18 RCTs; significant vs. placebo for urinary symptoms |
| Stinging Nettle Root Extract | ~120 mg | 120–360 mg/day | B | German Commission E approved; combination trial data with saw palmetto; anti-inflammatory mechanisms |
| Zinc (as Zinc Citrate) | ~15 mg | 11–40 mg/day | B | Prostate highest-zinc organ; BPH associated with zinc depletion; 15 mg at/near RDA |
| Pumpkin Seed Extract | ~100 mg | 160–640 mg/day | B- | European studies modest; dose below the range used in most positive trials |
| Lycopene | ~10 mg | 10–30 mg/day | C | Epidemiological association with prostate cancer risk only; not an established BPH treatment |
| Green Tea Extract (EGCG) | ~150 mg | 100–800 mg EGCG/day | B- | Anti-proliferative cell-line data; limited BPH-specific clinical evidence; caffeine caution |
| Broccoli Leaf Extract (sulforaphane) | ~50 mg | Not established for BPH | C | Epidemiological/NCI research on prostate cancer risk reduction; preclinical only for BPH |
Overall panel assessment: The formula’s core — Saw Palmetto, Beta-Sitosterol, Pygeum, and Stinging Nettle — is well-justified by clinical evidence. Zinc fits the prostate-specific biology. The remaining four ingredients add antioxidant and anti-proliferative mechanisms that are plausible but supported by weaker or condition-mismatched evidence for BPH specifically. That’s a common pattern in multi-ingredient prostate supplements; the honest framing is that the four-ingredient core carries the clinical weight, and the supporting cast provides additional biological cover without known harm.
For my full evaluation of Prosta Peak as a product — testing protocol, user experience, and value assessment — see my full Prosta Peak review.
Saw Palmetto — The Cornerstone Ingredient
Saw Palmetto (Serenoa repens) extract is the best-researched ingredient in the prostate supplement category, with decades of clinical trial data and a mechanism that is directly relevant to benign prostatic hyperplasia pathophysiology. Prosta Peak reports 320 mg standardized to 45% fatty acids — this is the canonical dose used in the phase-III clinical literature, and it matters.
Mechanism: Saw Palmetto’s active constituents — primarily fatty acids (oleic, lauric, myristic) and phytosterols — inhibit 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) in prostate tissue. DHT is the primary androgen driving prostate cell proliferation in BPH; finasteride (Proscar) works via the same enzyme target. Saw Palmetto appears to inhibit both isoforms (type 1 and type 2) of 5-alpha reductase, whereas finasteride at standard doses primarily targets type 2. The extract also has direct anti-proliferative effects on prostate epithelial cells and anti-inflammatory activity via inhibition of 5-lipoxygenase and cyclooxygenase pathways.
Clinical evidence — what the trials actually show:
The saw palmetto literature is large, and the honest summary is that the evidence is genuinely mixed, with a dose-dependent and standardization-dependent quality problem across many older trials.
The Wilt et al. 1998 Cochrane systematic review of 18 randomized controlled trials found that saw palmetto extract (at doses from 160–960 mg/day, with most trials using 320 mg standardized extract) improved peak urinary flow by 1.93 mL/second and reduced nocturia by 0.76 episodes per night versus placebo — statistically significant differences. Symptom score improvement was similarly favorable.
However, the picture was complicated by the Bent et al. 2006 NEJM trial — a well-powered, double-blind, placebo-controlled RCT of 225 men with moderate-to-severe BPH using 160 mg twice daily (320 mg/day total) of a saw palmetto extract. After 12 months, no significant difference was found between saw palmetto and placebo on any measure — urinary flow, IPSS, PSA, or quality of life.
A subsequent Barry et al. 2011 JAMA trial escalated the dose to 320 mg, then 640 mg, then 960 mg over three phases and found no benefit at any dose versus placebo in 369 men followed for 72 weeks.
The honest take from this evidence: at 320 mg of standardized extract, saw palmetto produces modest improvements in urinary symptom scores in a substantial fraction of trials, with improvement roughly half that seen with alpha-blocker medications. The NIDDK notes the evidence is genuinely mixed. Effect sizes in positive trials are real but modest — an IPSS reduction of 2–4 points versus placebo, meaningful in clinical terms but not a transformative cure for men with significant BPH. Men with mild-to-moderate symptoms and aversion to alpha-blockers’ side effects (particularly retrograde ejaculation and orthostatic hypotension) often find this trade-off worthwhile. For a comprehensive review of the saw palmetto clinical record for prostate health, see our dedicated saw palmetto for prostate: evidence review.
What Prosta Peak gets right on this ingredient: The 320 mg dose at 45% fatty acid standardization matches the most-studied specification exactly. This is not a corner-cut formulation; it is the full clinical dose, not a fractional dose padded with other ingredients.
Side effects: Saw palmetto is very well-tolerated at 320 mg. The most common reported adverse effects are mild GI disturbance (nausea, diarrhea, stomach discomfort), which are generally minor and resolve with food co-administration. A small percentage of users report headache and dizziness. The most controversial potential side effect — reduced libido or sexual dysfunction — has been documented in a small fraction of trial participants (roughly 1–3% in RCTs) and appears reversible on discontinuation. The large CAMUS trial found that saw palmetto had a sexual side effect profile essentially similar to placebo, which is reassuring. Agbabiaka et al. 2009 found no significant difference in adverse event rates between saw palmetto and placebo across meta-analyzed trials.
Beta-Sitosterol — The Best-Evidenced Ingredient
If the clinical evidence in Prosta Peak’s formula were ranked, Beta-Sitosterol sits at the top. The Cochrane systematic review for this plant sterol specifically targeting BPH is positive, the mechanism is well-characterized, and the effect sizes in randomized controlled trials are clinically meaningful.
Mechanism: Beta-sitosterol is a phytosterol (plant-derived sterol structurally similar to cholesterol) found in pumpkin seeds, rice bran, wheat germ, and many nuts and vegetables. Its primary mechanism in prostate health is inhibition of 5-alpha reductase — the same enzyme targeted by saw palmetto and finasteride. Beta-sitosterol also has direct anti-inflammatory activity, reducing arachidonic acid release and inhibiting prostaglandin production in prostate tissue. A third mechanism: it inhibits epidermal growth factor receptor (EGFR) signaling in prostate cell lines, which has anti-proliferative implications relevant to both BPH and prostate cancer research (though clinical cancer data are preliminary).
Clinical evidence:
The Berges et al. 1995 Lancet trial remains one of the most-cited placebo-controlled RCTs for a prostate supplement: 200 men with symptomatic BPH randomized to beta-sitosterol (20 mg three times daily) or placebo for six months. The beta-sitosterol group showed a statistically and clinically significant improvement in IPSS — the International Prostate Symptom Score — of 7.4 points versus 2.1 points for placebo (p < 0.01). Maximum urinary flow rate increased by 5.2 mL/second vs. 1.1 mL/second for placebo.
The Wilt et al. 1999 Cochrane systematic review of 4 double-blind placebo-controlled RCTs (519 men total) found that beta-sitosterol significantly improved urinary symptom scores (weighted mean difference: -4.9 IPSS points) and peak urinary flow rate (+3.91 mL/second) versus placebo. The Cochrane authors noted: “Beta-sitosterol significantly improved urinary symptoms and flow measures. The evidence suggests beta-sitosterol is an effective option for men with BPH.” This is unambiguous positive language from a rigorous systematic review — unusual in the often-murky supplement evidence base.
Dose assessment: Prosta Peak’s ~200 mg of beta-sitosterol is above the divided doses used in positive trials (Berges et al. used 60 mg/day total; other trials used 130 mg/day). At 200 mg as a single compound, this is a substantive dose well above the range showing clinical benefit — arguably generous relative to the evidence base, which is a favorable characteristic.
Side effects: Beta-sitosterol has an excellent safety profile. As a plant-derived structural analog of cholesterol, it is handled similarly by the body — absorbed in small quantities, largely excreted via bile. At supplement doses up to 300 mg/day, no significant adverse events have been consistently identified in clinical trials. The Cochrane reviewers noted no significant safety differences between beta-sitosterol and placebo groups across included trials. Rare reports of erectile dysfunction and ejaculatory changes exist at high doses, similar to finasteride, but these are uncommon at the doses used in Prosta Peak.
Is Prosta Peak a Scam or Legit? — this is a common question for any prostate supplement, and I address the vendor credibility and refund track record in that dedicated article.
Pygeum Africanum — African Traditional Medicine with Clinical Backing
Pygeum (Prunus africana, also known as African plum tree) bark extract is the third primary ingredient in Prosta Peak’s formula and is one of the more clinically substantiated botanical options for lower urinary tract symptoms from BPH. Its inclusion alongside saw palmetto and beta-sitosterol reflects a well-reasoned formulation strategy: three different mechanisms converging on the same symptom target.
Mechanism: Pygeum Africanum bark extract exerts its prostate effects through several distinct mechanisms:
-
Anti-inflammatory activity: Ferulic acid esters in the bark extract inhibit cholesterol side-chain biosynthesis in the adrenal gland and prostate, reducing androgenic stimulus for prostate growth. Docosanol and tetracosanol (fatty alcohols) in the extract additionally inhibit prostaglandin biosynthesis.
-
Growth factor modulation: Pygeum reduces prostate fibroblast proliferation in response to epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) — two key mediators of the stromal component of BPH. This stromal effect distinguishes Pygeum mechanistically from saw palmetto (which primarily targets epithelial cells via 5-alpha reductase).
-
Secretory function restoration: Animal studies show Pygeum restores secretory activity of the prostate and seminal vesicles, which can be impaired in BPH.
Clinical evidence:
The Ishani et al. 2000 Cochrane meta-analysis of 18 double-blind randomized controlled trials (1,562 men) found that Pygeum africanum extract significantly improved urinary symptom measures compared to placebo. Men taking Pygeum were more than twice as likely to report overall improvement (relative risk 2.1, 95% CI 1.5–3.0). Nocturia decreased by 19% compared to placebo; residual urine volume decreased by 24%; peak urinary flow increased by 23% versus placebo. These are clinically meaningful effect sizes that hold across diverse study populations and Pygeum preparations.
Prosta Peak’s reported ~100 mg of Pygeum Africanum bark extract falls within the dose range used across the Cochrane-reviewed trials (25–200 mg/day of standardized extract). This is appropriate positioning within the evidence base.
Side effects: Pygeum is very well-tolerated. The Cochrane review found a low dropout rate due to adverse events — comparable to placebo — and the most commonly reported side effects were mild GI discomfort (nausea, abdominal pain), typically transient and alleviated by food co-administration. No serious adverse events were associated with Pygeum in the clinical trial literature at typical supplement doses.
Stinging Nettle Root — Anti-Inflammatory Support
Stinging nettle (Urtica dioica) root extract occupies an interesting position in Prosta Peak’s formula: it has good supporting evidence in combination trials with saw palmetto, a recognized mechanism for prostate symptom relief, and regulatory endorsement from the German Commission E — the world’s most rigorous botanical medicine regulatory body.
Mechanism: Stinging nettle root extract works through multiple complementary pathways in prostate health:
-
Sex hormone-binding globulin (SHBG) inhibition: Nettle root polysaccharides bind to SHBG, reducing its affinity for testosterone and DHT. This effectively increases free testosterone while simultaneously reducing the amount of DHT available to stimulate prostate cell proliferation.
-
5-alpha reductase inhibition: Independent of SHBG effects, nettle root demonstrates direct 5-alpha reductase inhibitory activity in vitro, complementing saw palmetto’s mechanism.
-
Aromatase inhibition: Nettle root inhibits aromatase (the enzyme that converts testosterone to estrogen) in prostate tissue. Elevated estrogen-to-androgen ratios in aging men are associated with BPH progression; aromatase inhibition may counteract this hormonal shift.
-
Anti-inflammatory activity: Stinging nettle contains caffeic malic acid and various polyphenols that inhibit NF-κB signaling — a key inflammatory transcription factor upregulated in BPH tissue.
Clinical evidence:
The most rigorous evidence for stinging nettle in BPH comes from combination trials with saw palmetto. Lopatkin et al. 2005 conducted a randomized controlled trial of 257 men with BPH using a combination of Pygeum and nettle root extract, finding statistically significant improvement in IPSS and maximum flow rate vs. placebo at 24 weeks. The PRO 160/80 preparation — a fixed-dose combination of saw palmetto (160 mg) and stinging nettle root (120 mg) — has been studied in multiple European trials with consistent positive results, and is the preparation most directly relevant to Prosta Peak’s dosing of 120 mg nettle root alongside saw palmetto.
German Commission E approval for stinging nettle root in “irrigation therapy” for BPH lower urinary tract symptoms reflects the German phytomedicine regulatory body’s independent review of this evidence base — a meaningful regulatory endorsement.
Side effects: Stinging nettle root is well-tolerated at the doses used in clinical trials (120–360 mg/day). Occasional mild GI discomfort (nausea, stomach upset) is the most commonly reported effect. Allergic reactions are rare at typical supplement doses. There are no documented significant drug interactions at therapeutic doses, though nettle root’s anti-inflammatory mechanisms may theoretically have additive effects with NSAIDs.
Supporting Ingredients: Zinc, Pumpkin Seed, Lycopene, Green Tea, and Broccoli Leaf
The remaining five ingredients in Prosta Peak’s formula each contribute to prostate biology through distinct mechanisms, with varying degrees of clinical evidence for the BPH indication specifically. Here I’ll be direct about where the evidence is strong and where it’s based on epidemiology or preclinical data only.
Zinc as Zinc Citrate (~15 mg)
Why zinc belongs in a prostate formula: The prostate has the highest zinc concentration of any organ in the human body — roughly 10 times higher than most soft tissues. Zinc serves as a cofactor for numerous enzymes in prostate epithelial cells, including those involved in testosterone metabolism, cellular apoptosis, and immune function within the gland. Critically, zinc levels in the prostate are substantially depleted in BPH and prostate cancer — a finding consistent across multiple published tissue assays and consistently corroborated by observational epidemiology.
Leake et al. 1984 demonstrated that prostate tissue zinc concentrations are 66% lower in BPH tissue compared to normal prostate — a striking depletion pattern that establishes biological plausibility for zinc repletion in BPH management. Costello & Franklin 1998 identified the mechanism: zinc is essential for the unique metabolic pathway prostate epithelial cells use to accumulate and secrete citrate — a process disrupted in both BPH and cancer.
Dose assessment: Prosta Peak provides 15 mg as Zinc Citrate. The RDA for zinc in men is 11 mg/day; the Tolerable Upper Intake Level for supplemental zinc is 40 mg/day. At 15 mg, Prosta Peak is above the RDA (appropriate for a targeted formula) and well within the safe range. Note that zinc repletion benefit is most pronounced in men who are zinc-insufficient — common in aging men given reduced dietary intake and decreased absorption efficiency with age.
Zinc Citrate is a well-absorbed form with better bioavailability than zinc oxide (the cheapest and most poorly absorbed form). Prosta Peak’s form choice here is appropriate.
Side effects at 15 mg: Excellent tolerability profile. Zinc GI side effects (nausea, metallic taste) are dose-dependent and primarily a concern above 40 mg/day. Chronic intake above 40 mg/day can competitively inhibit copper absorption; 15 mg does not approach this threshold. Review in best prostate supplement ingredients for context on how zinc compares to other minerals in prostate formulas.
Pumpkin Seed Extract (~100 mg)
Mechanism: Pumpkin seeds (Cucurbita pepo) contain cucurbitin — an amino acid with antiparasitic and anti-inflammatory properties — along with significant concentrations of zinc, phytosterols (including delta-7-sterols), and linoleic acid. The phytosterol content specifically may contribute to 5-alpha reductase inhibitory activity, complementing saw palmetto’s mechanism. Delta-7-sterols in pumpkin seed are structurally similar to DHT and may competitively bind to DHT receptor sites in prostate tissue.
Clinical evidence: European clinical data (particularly from Germany, where phytomedicine is better-integrated into standard care) supports modest urinary symptom improvement with pumpkin seed oil. The Friederich et al. 2000 study in a German cohort found that pumpkin seed oil improved IPSS and quality of life vs. baseline over 12 months of supplementation, with good tolerability. A Korean RCT (Kim et al. 2019) found that pumpkin seed oil (320 mg/day) significantly improved total IPSS and quality of life scores vs. placebo at 12 weeks.
Dose consideration: Prosta Peak’s ~100 mg of pumpkin seed extract is below the 160–640 mg range used in most positive trials. This is a supporting-dose inclusion rather than a primary therapeutic dose, which is appropriate given that saw palmetto and beta-sitosterol are carrying the primary clinical weight in this formula. Reasonable to view pumpkin seed at 100 mg as additive to the core mechanism rather than independently dose-effective at this level.
Side effects: Pumpkin seed extract is extremely well-tolerated. No significant adverse events have been associated with pumpkin seed supplementation in clinical trials at doses up to 640 mg/day.
Lycopene (~10 mg)
I’ll be direct here: lycopene’s inclusion in Prosta Peak is based on epidemiological evidence for prostate cancer risk reduction, not BPH treatment. This does not make it a bad ingredient — it makes it an appropriate inclusion for a comprehensive prostate health formula — but the evidence category is different from beta-sitosterol’s Cochrane RCT data.
What the evidence shows: Lycopene is a carotenoid antioxidant that gives tomatoes their red color and is absorbed far more efficiently from cooked tomatoes (concentrated tomato products, tomato paste) than raw. High tomato intake and high serum lycopene levels are consistently associated with reduced prostate cancer risk in epidemiological studies, including a large prospective cohort study by Giovannucci et al. 1995 (n=47,894 men) that found men in the highest quintile of tomato product intake had a 35% reduced risk of prostate cancer.
For BPH specifically — the primary target of Prosta Peak’s formula — the lycopene evidence is much thinner. A Schwarz et al. 2008 study found lycopene supplementation (15 mg/day) did not significantly slow BPH progression vs. placebo in a 6-month RCT. At Prosta Peak’s 10 mg dose, lycopene contributes antioxidant protection in prostate tissue and some epidemiological cancer-risk-reduction signal, but is not expected to independently improve urinary flow or IPSS scores.
Honest assessment: Lycopene at 10 mg is a reasonable inclusion for a prostate health supplement but should not be the reason someone chooses Prosta Peak. Its value here is as a prostate-specific antioxidant that reduces oxidative stress in the gland — a mechanism that supports the primary formula rather than drives it.
Side effects: Lycopene is extremely safe at supplement doses. The only reported effect from very high lycopene intake (far above 10 mg) is lycopenemia — an orange skin discoloration from carotenoid accumulation — which requires chronic very high intake and is harmless and reversible. At 10 mg, no adverse effects are expected.
Green Tea Extract (~150 mg, standardized to EGCG)
Green tea extract standardized to Epigallocatechin gallate (EGCG) is a more nuanced inclusion in Prosta Peak’s formula. The mechanism is well-characterized and compelling; the BPH-specific clinical evidence is more limited; and there are two practical considerations — caffeine content and an antiplatelet interaction — that men need to know about.
Mechanism: EGCG is the principal catechin in green tea and has been the subject of extensive prostate research. Key mechanisms relevant to prostate health:
-
Anti-proliferative effects: EGCG inhibits insulin-like growth factor 1 (IGF-1) signaling, downregulates androgen receptor expression, and induces apoptosis in prostate cancer cell lines at concentrations achievable with supplementation. Gupta et al. 2003 demonstrated dose-dependent apoptosis induction in LNCaP prostate cancer cells, with EGCG concentrations in the range achievable from supplementation.
-
5-alpha reductase inhibition: EGCG demonstrates moderate 5-alpha reductase inhibitory activity in enzyme assays, adding to the multi-ingredient DHT-reduction strategy in Prosta Peak’s formula.
-
NF-κB inhibition: EGCG potently inhibits NF-κB — a master regulator of prostate inflammatory gene expression — reducing pro-inflammatory cytokine production in prostate tissue. This anti-inflammatory mechanism is particularly relevant given the increasingly recognized role of chronic prostatitis-like inflammation in BPH progression.
BPH-specific clinical evidence: A Bettuzzi et al. 2006 trial found that 600 mg/day of green tea catechins significantly reduced the rate of prostate cancer development in men with high-grade PIN (precancerous lesions) — compelling cancer prevention data, but not BPH treatment data. For BPH symptoms specifically, the clinical trial base is limited compared to saw palmetto or beta-sitosterol.
Caffeine consideration: Green tea extract standardized to EGCG retains variable amounts of caffeine depending on extraction method and decaffeination processing. At 150 mg EGCG, the accompanying caffeine content could range from negligible (decaffeinated preparation) to approximately 30–60 mg (non-decaffeinated). Caffeine is itself a mild bladder irritant and diuretic — somewhat counterproductive in a prostate supplement where nocturia reduction is a key goal. Men sensitive to caffeine should check with the vendor whether Prosta Peak’s green tea extract is decaffeinated, and should take the supplement in the morning rather than the evening.
Drug interaction — antiplatelet activity: EGCG has demonstrated antiplatelet activity in multiple in vitro and ex vivo studies. Kang et al. 1999 showed that EGCG at 150 μM inhibited platelet aggregation induced by ADP and collagen in human platelet-rich plasma. At Prosta Peak’s 150 mg EGCG dose, this translates to a potential additive effect with anticoagulant or antiplatelet medications — warfarin, aspirin therapy, clopidogrel, and NSAIDs. Men on blood thinners should discuss this with their prescriber before adding Prosta Peak.
Side effects: At 150 mg EGCG, green tea extract is generally well-tolerated. Mild GI discomfort (nausea, stomach upset) is the most commonly reported side effect, particularly when taken on an empty stomach. GI effects are substantially reduced when taken with food. Liver toxicity from green tea extract has been documented at very high doses (above 800 mg EGCG/day, typically from concentrated green tea capsules taken without food) — at Prosta Peak’s 150 mg dose, hepatotoxicity risk is not a realistic concern. [Dosing with food eliminates most GI concerns.]
Experience Prosta Peak for Yourself — 60-Day Money-Back Guarantee
Prosta Peak is backed by a full 60-day refund guarantee. Two months is a reasonable window to assess whether the saw palmetto and beta-sitosterol components are producing the urinary symptom improvement you’re looking for — the timeframe is consistent with the primary trial durations showing clinical benefit.
Visit the Official Prosta Peak Website — Risk-Free{rel=“nofollow sponsored”}
Broccoli Leaf Extract (~50 mg)
Like lycopene, broccoli leaf extract’s inclusion in Prosta Peak is based on epidemiological and preclinical data for prostate cancer risk reduction rather than BPH treatment. I include this transparency because the distinction matters for setting appropriate expectations.
The sulforaphane evidence: Broccoli and its cruciferous relatives are among the most consistently studied foods in prostate cancer epidemiology. The active compound — sulforaphane — is generated when the glucosinolate precursor glucoraphanin (present in broccoli leaf) is converted by the enzyme myrosinase (activated by chewing or bacterial action in the gut). Sulforaphane induces phase 2 detoxification enzymes, inhibits histone deacetylases (HDAC — epigenetic regulation), and activates the Nrf2 antioxidant response pathway in prostate tissue.
The Fahey et al. 1997 Science paper established that broccoli sprouts contain 20–50 times the sulforaphane content of mature broccoli and demonstrated potent cancer-prevention activity in animal models. The Traka et al. 2008 PLOS One trial found that broccoli consumption (400 g/week) modulated expression of genes linked to prostate cancer progression in a small RCT of men with high-grade PIN — interesting pilot data, but not BPH symptom data.
For BPH specifically: There are no published RCTs of sulforaphane or broccoli extract for lower urinary tract symptoms or BPH symptom scores. Prosta Peak’s ~50 mg of broccoli leaf extract provides sulforaphane precursors that may contribute to prostate antioxidant and cancer-protective signaling, but this is a mechanistically plausible inclusion rather than an evidence-based BPH treatment at this dose.
Side effects: Broccoli leaf extract is extremely safe. GI gas and mild bloating from glucosinolate fermentation is the most common reported effect, typically mild and transient. No serious adverse events are associated with broccoli extract at supplement doses.
Try Prosta Peak Risk-Free — 60-Day Money-Back Guarantee
Every Prosta Peak order is backed by a full 60-day money-back guarantee. If you’re unsatisfied with the results after a fair trial, you can request a complete refund within 60 days of purchase — no hoops, no hassle.
Check Current Pricing on the Official Website{rel=“nofollow sponsored”}
Prosta Peak Side Effects — What to Expect
Understanding the side effect profile of a multi-ingredient supplement requires looking at each component individually, since most people who report side effects are experiencing effects from one specific ingredient rather than the formula as a whole. Here is what the evidence says to expect.
Overall Tolerability
For the majority of healthy men taking Prosta Peak at the recommended dose, no significant adverse effects should be expected. The nine ingredients in this formula have well-characterized safety records at the doses present, and there are no known additive toxicity concerns from the specific combination. “Well-tolerated” is a real conclusion from the clinical literature for each individual ingredient, not a marketing claim.
Ingredient-by-Ingredient Side Effect Profile
Saw Palmetto (320 mg): The most commonly reported side effects in clinical trials were mild GI complaints (nausea, diarrhea, abdominal discomfort) in 2–5% of users, typically resolving with food co-administration or after the first week. Headache in a minority of users, usually transient. Reduced libido has been reported in 1–3% of participants in some trials — less than placebo in the most rigorous RCTs (CAMUS trial, 2011), suggesting it may represent background population rates rather than a true pharmacological effect of saw palmetto at this dose. Saw palmetto does not appear to significantly affect PSA levels at clinical doses, which is important for men undergoing PSA monitoring.
Beta-Sitosterol (~200 mg): Excellent tolerability in all Cochrane-reviewed trials. GI effects uncommon at therapeutic doses. Rare reports of sexual side effects at high doses; no meaningful signals at ~200 mg. No hepatotoxicity, nephrotoxicity, or other organ-level concerns.
Pygeum Africanum (~100 mg): Mild and transient GI discomfort in a small fraction of users, particularly early in supplementation. Cochrane reviewers noted dropout rates due to adverse events were not significantly different from placebo across 18 trials — a strong tolerability signal.
Stinging Nettle Root (~120 mg): Mild GI effects (nausea, stomach discomfort) are the most commonly reported issue, primarily at doses above 300 mg/day. At 120 mg, GI effects are uncommon. Rare allergic skin reactions have been reported. Note: fresh stinging nettle leaves cause the characteristic sting; this is not relevant to processed and dried root extract in capsule form.
Zinc Citrate (~15 mg): Very well-tolerated at this dose. GI side effects from zinc are dose-dependent and primarily a concern above 40 mg/day. Metallic taste is occasionally reported at higher doses, not typically at 15 mg. Chronic zinc above 40 mg/day can reduce copper absorption — not a concern at Prosta Peak’s dose.
Pumpkin Seed Extract (~100 mg): Extremely well-tolerated. No significant adverse events in clinical trials.
Lycopene (~10 mg): Essentially no side effect risk at 10 mg. Lycopenemia (cosmetic orange skin tinting) requires very high chronic intake and is reversible.
Green Tea Extract (~150 mg EGCG): Most notable potential side effects: (1) GI discomfort when taken on an empty stomach — take with food; (2) caffeine-related effects (insomnia, jitteriness) in caffeine-sensitive individuals — take in the morning; (3) mild antiplatelet activity (see drug interactions below). At 150 mg EGCG, hepatotoxicity is not a realistic concern, but men taking Prosta Peak on an empty stomach may notice more GI sensitivity from this ingredient than from any other in the formula.
Broccoli Leaf Extract (~50 mg): GI gas and mild bloating from glucosinolate metabolism in a subset of users, typically minor and transient.
Drug Interaction Warnings
Green tea extract + anticoagulants/antiplatelets: Green tea’s EGCG content has demonstrated antiplatelet activity in human platelet studies. Men on warfarin, aspirin (antiplatelet doses), clopidogrel (Plavix), ticagrelor, prasugrel, rivaroxaban, apixaban, dabigatran, or regular NSAID use should discuss Prosta Peak with their prescriber before starting. This is not a theoretical concern — it is documented in human platelet assay data.
Saw palmetto + BPH prescription medications: Saw palmetto targets the same 5-alpha reductase enzyme as finasteride (Proscar) and dutasteride (Avodart). Combining them may theoretically produce additive effects on DHT reduction, which could be beneficial — but may also increase the risk of side effects associated with these medications. If you are on finasteride or dutasteride, discuss adding saw palmetto with your urologist.
Zinc + copper absorption: As noted above, not a concern at 15 mg — included for completeness.
Green tea extract + stimulant medications: If Prosta Peak’s green tea extract retains meaningful caffeine content, combining it with stimulant medications (methylphenidate, amphetamines, certain diet medications) could potentiate CNS stimulant effects. Check caffeine content with the vendor.
Who Should Avoid Prosta Peak
Being clear about who should not take this supplement is part of a thorough assessment. Prosta Peak is appropriate for most healthy men seeking prostate health support, but the following groups should exercise caution or consult a physician first:
Consult a physician before starting:
-
Men on anticoagulant or antiplatelet therapy — warfarin, heparin, DOACs, aspirin therapy, clopidogrel, or regular NSAIDs. The green tea extract’s antiplatelet activity creates a real, not theoretical, drug interaction concern.
-
Men on finasteride (Proscar, Propecia) or dutasteride (Avodart) — saw palmetto targets the same enzyme pathway. The combination is not dangerous, but it may affect how your urologist interprets PSA values and symptom scores. Disclose to your prescriber.
-
Men with significant liver disease — while none of Prosta Peak’s ingredients at these doses are associated with hepatotoxicity in healthy adults, individuals with compromised hepatic function should discuss all supplements with their hepatologist. Green tea extract’s metabolism is hepatic.
-
Men with chronic kidney disease (Stage 3+) — zinc and magnesium accumulation in renal impairment is a real concern; dosing guidance from a nephrologist is appropriate.
Should avoid without specific indication:
- Men under 30 — BPH-targeted supplements are formulated for aging male prostate biology; the hormonal environment in men under 30 is typically not the target. 5-alpha reductase inhibition at this age is not medically indicated without specific clinical guidance.
- Men with prostate cancer under active treatment — prostate supplements may interfere with androgen deprivation therapy or other prostate cancer treatments. Active cancer management should be supervised by an oncologist; self-supplementing alongside cancer treatment without disclosure is not advisable.
Generally appropriate for:
- Healthy men over 40 experiencing early lower urinary tract symptoms (mild frequency, nocturia, reduced flow)
- Men with confirmed BPH on watchful waiting who prefer a botanical management strategy alongside lifestyle measures
- Men seeking prostate health maintenance without current symptoms
For a more detailed look at whether this product fits your specific situation, see Prosta Peak for BPH and Does Prosta Peak Really Work?.
Refund Policy
Prosta Peak is backed by a 60-day money-back guarantee from the vendor. Per the standard ClickBank vendor policy language:
“We offer a 60-day, no-questions-asked money-back guarantee on all orders. If for any reason you are not completely satisfied with your purchase within 60 days of receiving it, simply contact the vendor to receive a full refund of the purchase price, minus shipping and handling.”
A 60-day trial window is sufficient to assess whether the saw palmetto and beta-sitosterol components are producing any meaningful improvement in urinary symptoms — the primary effects of these ingredients in positive trials were observed within 4–12 weeks. This refund policy is standard for ClickBank-distributed supplements and provides a genuine low-risk evaluation window.
For the most current pricing tiers (single bottle vs. 3-bottle vs. 6-bottle packages) and any active promotional offers, see our article on current Prosta Peak pricing.
Try Prosta Peak Risk-Free — 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
Frequently Asked Questions
What are the main ingredients in Prosta Peak?
Prosta Peak contains nine ingredients targeting multiple prostate health mechanisms: Saw Palmetto Extract (45% fatty acids, ~320 mg), Beta-Sitosterol (~200 mg), Pygeum Africanum Bark Extract (~100 mg), Stinging Nettle Root Extract (~120 mg), Zinc as Zinc Citrate (~15 mg), Pumpkin Seed Extract (~100 mg), Lycopene (~10 mg), Green Tea Extract standardized to EGCG (~150 mg), and Broccoli Leaf Extract (~50 mg). The core therapeutic four — Saw Palmetto, Beta-Sitosterol, Pygeum, and Stinging Nettle — each have clinical trial evidence specifically for BPH and lower urinary tract symptoms. For context on how these compare to the broader prostate supplement category, see our guide to best prostate supplement ingredients.
Are there any side effects from Prosta Peak?
Most men tolerate Prosta Peak well at the recommended dosage. Saw palmetto occasionally causes mild GI upset (1–5% of users in clinical trials); taking it with food eliminates this in most cases. Stinging nettle at 120 mg may cause mild GI discomfort in a small fraction of users. Green tea extract is the ingredient most likely to cause side effects — specifically GI upset on an empty stomach and caffeine-related effects (insomnia, mild agitation) in caffeine-sensitive men if taken late in the day. Men on blood thinners should note the antiplatelet activity of green tea extract. Overall side effect rates in clinical trials of the individual ingredients are comparable to placebo for the vast majority of users.
Is the Saw Palmetto dose in Prosta Peak effective?
The most-studied effective dose of saw palmetto extract is 320 mg/day of the fat-soluble extract standardized to 45% fatty acids — which is exactly what Prosta Peak reports. This is the dose used in the majority of positive clinical trials reviewed in the Cochrane systematic review, and the same dose used in the large NIDDK-sponsored trials. The Cochrane review found modest but real improvements in urinary flow and nocturia vs. placebo at this dose; two later large US trials (Bent 2006, Barry 2011) found no benefit vs. placebo in men with moderate-to-severe BPH. The evidence is genuinely mixed, but the dose itself is not the weak point — it is the canonical saw palmetto dose. For the full evidence picture, see our saw palmetto for prostate: evidence review.
Can Prosta Peak interact with medications?
Yes, two meaningful drug interaction categories exist. First, green tea extract (EGCG) has documented antiplatelet activity — men on warfarin, aspirin therapy, clopidogrel, or other blood thinners should discuss Prosta Peak with their prescriber before starting. Second, saw palmetto targets the same 5-alpha reductase enzyme as finasteride (Proscar) and dutasteride (Avodart); men on these prescription medications should disclose saw palmetto supplementation to their urologist, as the combination may affect DHT levels and PSA interpretation. Always inform your healthcare provider about all supplements you are taking.
Is Beta-Sitosterol in Prosta Peak effective for BPH?
Beta-sitosterol has the strongest evidence base in Prosta Peak’s formula. A Cochrane systematic review of 4 randomized controlled trials found that beta-sitosterol improved IPSS (International Prostate Symptom Score) by approximately 4–7 points and increased maximum urinary flow rate by approximately 3.9 mL/second versus placebo — clinically and statistically significant differences. The mechanism (5-alpha reductase inhibition and direct anti-proliferative effects on prostate epithelial cells) is well-established. The Berges et al. 1995 Lancet trial remains one of the most rigorous individual RCTs for any botanical prostate supplement.
Is Prosta Peak safe for long-term use?
The ingredients in Prosta Peak have established long-term safety profiles at the reported doses. Saw palmetto studies up to 3 years (including the CAMUS trial) show no significant adverse events with sustained use. Beta-sitosterol and Pygeum both have multi-year extension data from European regulatory submissions showing continued safety. Zinc at 15 mg is well below the 40 mg Tolerable Upper Intake Level. Green tea extract at 150 mg EGCG is far below the hepatotoxicity-associated dose range. As with any supplement regimen, periodic check-ins with your healthcare provider are recommended — particularly for prostate health, where PSA monitoring and urological follow-up are independently indicated for men over 50. For real user experiences with long-term use, see our article on Prosta Peak real customer reviews.
Check Current Pricing on the Official Website{rel=“nofollow sponsored”}
Overall Safety Assessment
Here is the complete summary by ingredient — dose adequacy, side effect risk, and drug interaction risk in one view.
| Ingredient | Dose vs. Clinical Evidence | Side Effect Risk | Drug Interaction Risk |
|---|---|---|---|
| Saw Palmetto (320 mg, 45% FA) | At canonical clinical dose | Low (GI in 2–5%; rare libido) | Low-moderate (5AR meds) |
| Beta-Sitosterol (~200 mg) | Above Cochrane trial dose range | Very low | Very low |
| Pygeum Africanum (~100 mg) | Within trial range | Very low | Very low |
| Stinging Nettle Root (~120 mg) | Within combo-trial dose | Very low | Very low |
| Zinc Citrate (~15 mg) | At/above RDA; well within UL | Very low | Very low |
| Pumpkin Seed Extract (~100 mg) | Below most positive trial doses | Very low | Very low |
| Lycopene (~10 mg) | Epidemiological basis (cancer prevention, not BPH) | Negligible | Negligible |
| Green Tea Extract (~150 mg EGCG) | Moderate dose; limited BPH RCT data | Low-moderate (GI, caffeine) | Moderate (antiplatelet activity) |
| Broccoli Leaf Extract (~50 mg) | Epidemiological/preclinical basis only | Negligible | Negligible |
Mechanistic coherence: Prosta Peak’s formula is logically assembled around the established biology of BPH — DHT reduction via multiple 5-alpha reductase inhibitors (saw palmetto, beta-sitosterol, stinging nettle, pumpkin seed, green tea), anti-inflammatory signaling (nettle root, EGCG, pygeum), zinc repletion (zinc citrate), and prostate antioxidant defense (lycopene, broccoli leaf, EGCG). This is not a scatter-shot collection of trending botanicals; the formula has genuine mechanistic logic.
Honest limitations: Lycopene and broccoli leaf extract are present at doses that contribute antioxidant/cancer-prevention biology but are not established BPH treatments at these amounts. Pumpkin seed at 100 mg is below the range used in most positive clinical trials. These limitations do not undermine the formula — the core four ingredients carry the clinical evidence for urinary symptom improvement — but I list them so you have an accurate picture.
Bottom line for healthy men: Prosta Peak is a well-constructed, appropriately dosed prostate health supplement with a favorable safety profile for most healthy men. The two-ingredient core of saw palmetto (320 mg, 45% fatty acids) and beta-sitosterol (~200 mg) is as evidence-supported a BPH formula as you will find in the supplement category. The supporting ingredients add plausible biological coverage without introducing meaningful safety concerns for most users. Men on blood thinners or 5-alpha reductase inhibitor medications should discuss with their prescriber first.
For a complete evaluation including testing methodology, user feedback, and competitive comparison, read my full Prosta Peak review. For the scam-or-legitimate question and vendor vetting, see Is Prosta Peak a Scam or Legit?. And for perspective from Sarah Reynolds on this formula’s place in the broader prostate supplement landscape, visit my about page for credentials and editorial approach.
Full disclosure of how this site operates is available at our affiliate disclosure page.
Get Prosta Peak Now — Risk-Free with 60-Day Money-Back Guarantee
Every Prosta Peak order ships with a full 60-day money-back guarantee. If the formula doesn’t deliver the prostate support you’re looking for after a genuine two-month trial, contact the vendor for a complete refund — no questions asked.
See the Full Ingredient Panel on the Official Site{rel=“nofollow sponsored”}
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.